Gossamer Bio Shares Plummet as Lung Disease Drug Fails Late-stage Trial



Gossamer Bio’s experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug…
Reuters Health Information



Source link : https://www.medscape.com/s/viewarticle/gossamer-bios-experimental-lung-disease-drug-fails-late-2026a10005lj?src=rss

Author :

Publish date : 2026-02-23 13:10:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version